Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001994516 | SCV002229814 | pathogenic | not provided | 2023-05-05 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 1452296). This variant has not been reported in the literature in individuals affected with VPS13A-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Ile1152Metfs*6) in the VPS13A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in VPS13A are known to be pathogenic (PMID: 12404112, 21598378). |
Fulgent Genetics, |
RCV005042587 | SCV005675862 | likely pathogenic | Chorea-acanthocytosis | 2024-04-29 | criteria provided, single submitter | clinical testing |